NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

CompletedN/A

Sponsor: Pfizer

Conditions: Transthyretin Familial Amyloid Polyneuropathy

Interventions: Vyndaqel

The purpose of this study is to understand safety (e.g., occurrence of adverse drug reactions \[ADRs\]) and efficacy data on the long-term use of Vyndaqel Capsules (hereinafter referred to as Vyndaqel) in all patients who received this drug under actual use conditions after its marketing.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

The subjects of this surveillance are all patients who received Vyndaqel.

Exclusion Criteria:

Patients not receive Vyndaqel.